NovaBridge Biosciences: cost_of_revenue
| Value | {"amount": 3949000, "concept": "us-gaap:CostOfRevenue", "currency": "USD"} |
|---|---|
| Period | 2022-01-01 – 2022-12-31 |
| Status | current |
| Entity | NovaBridge Biosciences |
Provenance
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference:
Retrieved: 2026-08-19T18:00:43.919806+02:00
Raw response sha256:
Also addressable by official identifiers:
Cite as: FACTANKER, https://factanker.com/fact/b980504d-eade-46a7-9571-4882c636e52f
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference:
0001104659-23-053462Retrieved: 2026-08-19T18:00:43.919806+02:00
Raw response sha256:
f7bde1a401b286c74a2fd824ee1df541…Also addressable by official identifiers:
https://factanker.com/fact/sec/cik-0001778016/cost-of-revenue/2022-12-31 (CIK, metric, reporting date)Cite as: FACTANKER, https://factanker.com/fact/b980504d-eade-46a7-9571-4882c636e52f
History
- supersedes {"unit": "CNY", "value": 27237000, "concept": "us-gaap:CostOfRevenue"} (evidence 0001104659-23-053462)